import Link from "next/link";
import JsonLd from "@/components/JsonLd";
import ContactLink from "@/components/ContactLink";
import { buildPageMetadata } from "@/lib/seo";
import { faqPageJsonLd, isWhereToBuy } from "@/lib/faq-schema";

export const metadata = buildPageMetadata({
  path: "/compare/aod-9604-vs-mots-c",
  title: "AOD-9604 vs MOTS-C: Two Distinct Metabolic Peptides | Prof. Peptide",
  description:
    "AOD-9604 (an hGH fat-loss fragment) and MOTS-C (a mitochondrial-derived peptide) are two distinct metabolic peptides with different mechanisms.",
});

const rows = [
  ["What it is", "Synthetic fragment of human growth hormone — the hGH 176-191 C-terminal region", "Mitochondrial-derived peptide (MDP) encoded in mitochondrial DNA (12S rRNA region); 16 amino acids"],
  ["Origin", "Lab-synthesized; modeled on the fat-metabolism (lipolytic) domain of hGH", "Naturally occurring — produced by your own mitochondria"],
  ["Mechanism", "Stimulates lipolysis / fat oxidation, mimicking hGH's effect on fat metabolism — reportedly without hGH's growth (IGF-1) or blood-sugar effects", "Activates AMPK and regulates metabolic homeostasis / insulin sensitivity — behaves as an “exercise mimetic”"],
  ["Primary research question", "Selective fat loss / lipolysis", "Insulin sensitivity, metabolic homeostasis, exercise-mimetic and mitochondrial/longevity biology"],
  ["Evidence stage", "Largely preclinical; human fat-loss trials were underwhelming — Phase 2 development was discontinued (2007)", "Early — strong preclinical foundation (Lee et al., Cell Metab 2015); human/Phase 1 work only beginning"],
  ["FDA status", "Not FDA-approved; FDA declined the 503A Bulks List (Dec 2024)", "Not FDA-approved; research-use only"],
  ["WADA", "Prohibited", "Not specifically named on the prohibited list (status uncertain)"],
  ["Route (research)", "Subcutaneous injection", "Subcutaneous injection"],
];

const faqs = [
  { q: "Are AOD-9604 and MOTS-C the same?", a: <>No &mdash; they are genuinely different compounds. AOD-9604 is a synthetic fragment of human growth hormone (the hGH 176-191 region), while MOTS-C is a mitochondrial-derived peptide encoded in mitochondrial DNA. Different origins, different structures, and different mechanisms. They overlap only in that both are studied in a metabolic context.</> },
  { q: "Do they work the same way?", a: <>No. AOD-9604 stimulates lipolysis (fat breakdown) and fat oxidation, modeled on the fat-metabolism domain of growth hormone — reportedly without hGH&apos;s growth or blood-sugar effects. MOTS-C works upstream on cellular energy metabolism, activating AMPK and improving insulin sensitivity as an &ldquo;exercise mimetic.&rdquo; Overlapping interest (metabolism), different pathways.</> },
  { q: "Which is better for fat-loss research?", a: <>There isn&apos;t a clean winner. AOD-9604 was purpose-built as a lipolytic fragment, so it is the more direct fat-loss mechanism on paper — but its human fat-loss trials were disappointing and Phase 2 development was discontinued. MOTS-C targets metabolic regulation and insulin sensitivity more than direct fat-burning, with promising but early evidence. The right choice depends on the exact research question, not a ranking.</> },
  { q: "Are either AOD-9604 or MOTS-C FDA-approved?", a: <>No. Neither is FDA-approved. AOD-9604&apos;s Phase 2 development was discontinued in 2007 and the FDA declined to add it to the 503A Bulks List (Dec 2024); it is also WADA-prohibited. MOTS-C is research-use-only with human/Phase 1 work only beginning. Both are sold research-use-only.</> },
  { q: "Can they be studied together?", a: (
    <>
      They act through different pathways (lipolysis vs AMPK/metabolic homeostasis), so a researcher might study them for complementary metabolic questions &mdash; and they are sold together as a{" "}
      <Link href="/peptides/aod-9604-mots-c" className="text-[#0891b2] hover:underline">combined AOD-9604 + MOTS-c blend</Link>. That said, there is no established combination protocol, and human evidence for either compound is limited. Research-use only.
    </>
  ) },
];

export default function AOD9604vsMOTScPage() {
  return (
    <>
      <JsonLd data={{"@context":"https://schema.org","@type":"Article","headline":"AOD-9604 vs MOTS-C: Two Distinct Metabolic Peptides","description":"AOD-9604 (a synthetic hGH fat-loss fragment) and MOTS-C (a mitochondrial-derived peptide) are two distinct metabolic peptides with different mechanisms — how they compare and what each is studied for.","url":"https://profpeptide.com/compare/aod-9604-vs-mots-c","publisher":{"@type":"Organization","name":"Prof. Peptide","url":"https://profpeptide.com"}}} />
      <JsonLd data={{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://profpeptide.com"},{"@type":"ListItem","position":2,"name":"Comparisons","item":"https://profpeptide.com/compare"},{"@type":"ListItem","position":3,"name":"AOD-9604 vs MOTS-C: Two Distinct Metabolic Peptides"}]}} />
      <JsonLd data={faqPageJsonLd(faqs, isWhereToBuy)} />
    <div className="section max-w-4xl">
      <Link href="/compare" className="text-sm text-[#0891b2] hover:underline mb-6 inline-block">&larr; Back to Comparisons</Link>
      <h1 className="text-3xl font-bold text-[#1e2d3d] dark:text-slate-100 mb-3">AOD-9604 vs MOTS-C &mdash; Two Distinct Metabolic Peptides</h1>
      <p className="text-lg text-gray-500 dark:text-slate-400 leading-relaxed mb-8 max-w-2xl"><Link href="/peptides/aod-9604" className="text-[#0891b2] hover:underline">AOD-9604</Link> and <Link href="/peptides/mots-c" className="text-[#0891b2] hover:underline">MOTS-C</Link> both show up in fat-loss and metabolic research, so they get compared &mdash; but unlike some &ldquo;versus&rdquo; pairs, these are two genuinely different compounds that work through different mechanisms. This page lays out what each actually is, how they differ, and which research question each fits.</p>

      <div className="bg-[#0891b2]/10 border border-[#0891b2]/20 rounded-xl p-5 mb-8">
        <p className="text-lg text-[#1e2d3d] dark:text-slate-100 mb-2"><strong>AOD-9604:</strong> a synthetic fragment of growth hormone (hGH 176-191), studied for selective fat loss / lipolysis.</p>
        <p className="text-lg text-[#1e2d3d] dark:text-slate-100 mb-2"><strong>MOTS-C:</strong> a mitochondrial-derived peptide (encoded in mtDNA), studied for insulin sensitivity and metabolic homeostasis as an &ldquo;exercise mimetic.&rdquo;</p>
        <p className="text-lg text-[#1e2d3d] dark:text-slate-100"><strong>Bottom line up front:</strong> different compounds, different mechanisms &mdash; not interchangeable, and not a rigged &ldquo;which is better&rdquo; contest. Both are preclinical-stage and research-use only.</p>
      </div>

      <div className="mb-8 p-5 border border-[#0891b2]/20 bg-[#0891b2]/10 rounded-xl">
        <h2 className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 mb-3">Why these two get compared</h2>
        <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed mb-3">
          Both are peptides that touch fat and energy metabolism, so they end up on the same shortlists. But they come from completely different places. AOD-9604 is a lab-made fragment of human growth hormone, engineered to isolate the hormone&apos;s fat-metabolism (lipolytic) action while leaving out its growth and blood-sugar effects.
        </p>
        <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed mb-3">
          MOTS-C is something categorically different: a peptide encoded in mitochondrial DNA that your own mitochondria produce. Rather than acting like a fat-burning hormone fragment, it works upstream on cellular energy sensing &mdash; activating AMPK and improving insulin sensitivity, which is why it is described as an &ldquo;exercise mimetic.&rdquo;
        </p>
        <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          So the honest comparison isn&apos;t &ldquo;which fat-loss peptide wins&rdquo; &mdash; it&apos;s two different tools aimed at overlapping-but-distinct metabolic questions, both still early in the evidence.
        </p>
      </div>

      <div className="overflow-x-auto mb-8">
        <table className="w-full text-sm border-collapse">
          <thead>
            <tr className="bg-gray-50 dark:bg-[#1e293b]">
              <th className="text-left px-4 py-3 font-semibold text-gray-400 dark:text-slate-500 text-xs uppercase tracking-wider border-b border-gray-100 dark:border-slate-700 w-1/4"></th>
              <th className="text-left px-4 py-3 font-semibold text-[#0891b2] text-xs uppercase tracking-wider border-b border-gray-100 dark:border-slate-700 w-[37.5%]">AOD-9604</th>
              <th className="text-left px-4 py-3 font-semibold text-[#0891b2] text-xs uppercase tracking-wider border-b border-gray-100 dark:border-slate-700 w-[37.5%]">MOTS-C</th>
            </tr>
          </thead>
          <tbody>
            {rows.map(([label, a, b], i) => (
              <tr key={i} className={i % 2 === 0 ? "bg-white dark:bg-[#0f172a]" : "bg-gray-50/50 dark:bg-slate-800/50"}>
                <td className="px-4 py-3 font-medium text-[#1e2d3d] dark:text-slate-100 border-b border-gray-100 dark:border-slate-700">{label}</td>
                <td className="px-4 py-3 text-gray-600 dark:text-slate-300 border-b border-gray-100 dark:border-slate-700">{a}</td>
                <td className="px-4 py-3 text-gray-600 dark:text-slate-300 border-b border-gray-100 dark:border-slate-700">{b}</td>
              </tr>
            ))}
          </tbody>
        </table>
      </div>

      <div className="mb-8">
        <h2 className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">Which fits which research question?</h2>
        <p className="text-lg text-gray-500 dark:text-slate-400 leading-relaxed mb-4">
          Both are research-use-only and neither is FDA-approved. Because the mechanisms differ, the choice is about the question you&apos;re studying, not a ranking.
        </p>
        <div className="space-y-4">
          <div className="border border-gray-100 dark:border-slate-700 rounded-xl p-5">
            <h3 className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">Studying selective fat loss / lipolysis</h3>
            <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
              AOD-9604 is the more direct mechanistic match &mdash; it was purpose-built as a lipolytic fragment of growth hormone. Temper expectations, though: its preclinical fat-oxidation results did not carry over into successful human weight-loss trials, and Phase 2 development was discontinued. It is a mechanism worth studying, not a proven fat-loss agent.
            </p>
          </div>
          <div className="border border-gray-100 dark:border-slate-700 rounded-xl p-5">
            <h3 className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">Studying insulin sensitivity, metabolic homeostasis, or exercise-mimetic biology</h3>
            <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
              MOTS-C is the relevant tool. Its landmark Cell Metabolism work showed it improves metabolic homeostasis and insulin sensitivity via AMPK, positioning it as an exercise-mimetic and mitochondrial/longevity research compound rather than a direct fat-burner. The human evidence is early, so treat findings as preliminary.
            </p>
          </div>
          <div className="border border-gray-100 dark:border-slate-700 rounded-xl p-5">
            <h3 className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">Both together</h3>
            <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
              Because they hit different pathways, they are sometimes combined &mdash; sold as a <Link href="/peptides/aod-9604-mots-c" className="text-[#0891b2] hover:underline">AOD-9604 + MOTS-c blend</Link>. There is no established combination protocol and the human data for each is limited, so any combined use is exploratory and research-use only.
            </p>
          </div>
        </div>
      </div>

      <div className="border border-gray-100 dark:border-slate-700 rounded-xl p-5 mb-8">
        <h2 className="text-xl font-bold text-[#1e2d3d] dark:text-slate-100 mb-2">Bottom Line</h2>
        <p className="text-lg text-gray-600 dark:text-slate-300">AOD-9604 and MOTS-C are two distinct metabolic peptides, not variants of one another. AOD-9604 is a synthetic growth-hormone fragment aimed at lipolysis; its mechanism is direct but its human fat-loss evidence is weak (Phase 2 discontinued). MOTS-C is a mitochondrial-derived peptide aimed at AMPK-driven metabolic homeostasis and insulin sensitivity, with a strong preclinical base but only early human data. Pick by research question, not by a &ldquo;winner&rdquo; &mdash; and note both are preclinical-stage, not FDA-approved, and research-use only.</p>
      </div>

      <div className="mb-8">
        <h2 className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 mb-4">FAQ</h2>
        <div className="space-y-4">
          {faqs.map((f, i) => (
            <div key={i}>
              <h3 className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 mb-1">{f.q}</h3>
              <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">{f.a}</p>
            </div>
          ))}
        </div>
      </div>

      <div className="mb-8">
        <h2 className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 mb-3">References</h2>
        <ol className="list-decimal list-inside space-y-2">
          <li className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
            Ng FM, Sun J, Sharma L, et al. Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone. Horm Res. 2000;53(6):274-278.{" "}
            <a href="https://pubmed.ncbi.nlm.nih.gov/11146367/" target="_blank" rel="noopener noreferrer" className="text-[#0891b2] hover:underline break-words">https://pubmed.ncbi.nlm.nih.gov/11146367/</a>
          </li>
          <li className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
            Heffernan MA, Thorburn AW, Fam B, et al. Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment. Int J Obes Relat Metab Disord. 2001;25(10):1442-1449.{" "}
            <a href="https://pubmed.ncbi.nlm.nih.gov/11673763/" target="_blank" rel="noopener noreferrer" className="text-[#0891b2] hover:underline break-words">https://pubmed.ncbi.nlm.nih.gov/11673763/</a>
          </li>
          <li className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
            Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-454.{" "}
            <a href="https://pubmed.ncbi.nlm.nih.gov/25738459/" target="_blank" rel="noopener noreferrer" className="text-[#0891b2] hover:underline break-words">https://pubmed.ncbi.nlm.nih.gov/25738459/</a>
          </li>
          <li className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
            Zheng Y, Wei Z, Wang T. MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation. Front Endocrinol (Lausanne). 2023.{" "}
            <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9905433/" target="_blank" rel="noopener noreferrer" className="text-[#0891b2] hover:underline break-words">https://pmc.ncbi.nlm.nih.gov/articles/PMC9905433/</a>
          </li>
        </ol>
      </div>

      <div className="flex flex-wrap gap-3 mb-8">
        <Link href="/peptides/aod-9604" className="btn-primary text-sm">AOD-9604 Profile</Link>
        <Link href="/peptides/mots-c" className="btn-outline text-sm">MOTS-C Profile</Link>
        <Link href="/peptides/aod-9604-mots-c" className="btn-outline text-sm">AOD-9604 + MOTS-c Blend</Link>
      </div>

      <p className="text-xs text-gray-400 dark:text-slate-500 leading-relaxed">For educational and research purposes only. Not medical advice. Not for human use.</p>
    <ContactLink pageName="AOD-9604 vs MOTS-C — Two Distinct Metabolic Peptides" pagePath="/compare/aod-9604-vs-mots-c" />
    </div>
    </>
  );
}
